Maternal and developmental toxicity of manganese in the mouse

Domenec J. Sánchez, JoséL Domingo, Juan M. Llobet, Carl L Keen

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Manganese (II) chloride tetrahydrate was investigated in Swiss mice for maternal and developmental toxicity after subcutaneous (s.c.) exposure to doses of 0, 2, 4, 8 and 16 mg/kg per day from gestation day 6 through 15. Females were sacrificed on gestation day 18, and fetuses were examined for external, visceral, and skeletal abnormalities. Maternal toxicity included significant reductions in weight gain and food consumption at 8 and 16 mg/kg/day, as well as several treatment-related deaths in the high dose-group. There were no treatment-related effects on the number of total implants, early resorptions, dead fetuses or sex ratio, whereas a significant increase in the number of late resorptions was found in the 4, 8, and 16 mg/kg/day groups. Fetotoxicity, consisting primarily of reduced fetal body weight and an increased incidence of morphological defects was also observed at 8 and 16 mg/kg/day. There were no differences between control and manganese-treated groups in the incidence of individual or total malformations. The no observable adverse effect level (NOAEL) for maternal toxicity of MnCl2· 4H20 in mice was 4 mg/kg/day, while the NOAEL for embryo/fetal toxicity was 2 mg/kg/day.

Original languageEnglish (US)
Pages (from-to)45-52
Number of pages8
JournalToxicology Letters
Volume69
Issue number1
DOIs
StatePublished - 1993

Fingerprint

Manganese
Toxicity
Mothers
Fetus
Pregnancy
Fetal Weight
Incidence
Sex Ratio
Weight Gain
Embryonic Structures
Chlorides
Food
Defects
manganese chloride

Keywords

  • Embryolethality
  • Fetotoxicity
  • Manganese (II) chloride
  • Maternal Toxicity
  • Mice

ASJC Scopus subject areas

  • Toxicology

Cite this

Sánchez, D. J., Domingo, J., Llobet, J. M., & Keen, C. L. (1993). Maternal and developmental toxicity of manganese in the mouse. Toxicology Letters, 69(1), 45-52. https://doi.org/10.1016/0378-4274(93)90144-M

Maternal and developmental toxicity of manganese in the mouse. / Sánchez, Domenec J.; Domingo, JoséL; Llobet, Juan M.; Keen, Carl L.

In: Toxicology Letters, Vol. 69, No. 1, 1993, p. 45-52.

Research output: Contribution to journalArticle

Sánchez, DJ, Domingo, J, Llobet, JM & Keen, CL 1993, 'Maternal and developmental toxicity of manganese in the mouse', Toxicology Letters, vol. 69, no. 1, pp. 45-52. https://doi.org/10.1016/0378-4274(93)90144-M
Sánchez, Domenec J. ; Domingo, JoséL ; Llobet, Juan M. ; Keen, Carl L. / Maternal and developmental toxicity of manganese in the mouse. In: Toxicology Letters. 1993 ; Vol. 69, No. 1. pp. 45-52.
@article{ac422444fe5b48d7aebe9c7d3495241f,
title = "Maternal and developmental toxicity of manganese in the mouse",
abstract = "Manganese (II) chloride tetrahydrate was investigated in Swiss mice for maternal and developmental toxicity after subcutaneous (s.c.) exposure to doses of 0, 2, 4, 8 and 16 mg/kg per day from gestation day 6 through 15. Females were sacrificed on gestation day 18, and fetuses were examined for external, visceral, and skeletal abnormalities. Maternal toxicity included significant reductions in weight gain and food consumption at 8 and 16 mg/kg/day, as well as several treatment-related deaths in the high dose-group. There were no treatment-related effects on the number of total implants, early resorptions, dead fetuses or sex ratio, whereas a significant increase in the number of late resorptions was found in the 4, 8, and 16 mg/kg/day groups. Fetotoxicity, consisting primarily of reduced fetal body weight and an increased incidence of morphological defects was also observed at 8 and 16 mg/kg/day. There were no differences between control and manganese-treated groups in the incidence of individual or total malformations. The no observable adverse effect level (NOAEL) for maternal toxicity of MnCl2· 4H20 in mice was 4 mg/kg/day, while the NOAEL for embryo/fetal toxicity was 2 mg/kg/day.",
keywords = "Embryolethality, Fetotoxicity, Manganese (II) chloride, Maternal Toxicity, Mice",
author = "S{\'a}nchez, {Domenec J.} and Jos{\'e}L Domingo and Llobet, {Juan M.} and Keen, {Carl L}",
year = "1993",
doi = "10.1016/0378-4274(93)90144-M",
language = "English (US)",
volume = "69",
pages = "45--52",
journal = "Toxicology Letters",
issn = "0378-4274",
publisher = "Elsevier BV",
number = "1",

}

TY - JOUR

T1 - Maternal and developmental toxicity of manganese in the mouse

AU - Sánchez, Domenec J.

AU - Domingo, JoséL

AU - Llobet, Juan M.

AU - Keen, Carl L

PY - 1993

Y1 - 1993

N2 - Manganese (II) chloride tetrahydrate was investigated in Swiss mice for maternal and developmental toxicity after subcutaneous (s.c.) exposure to doses of 0, 2, 4, 8 and 16 mg/kg per day from gestation day 6 through 15. Females were sacrificed on gestation day 18, and fetuses were examined for external, visceral, and skeletal abnormalities. Maternal toxicity included significant reductions in weight gain and food consumption at 8 and 16 mg/kg/day, as well as several treatment-related deaths in the high dose-group. There were no treatment-related effects on the number of total implants, early resorptions, dead fetuses or sex ratio, whereas a significant increase in the number of late resorptions was found in the 4, 8, and 16 mg/kg/day groups. Fetotoxicity, consisting primarily of reduced fetal body weight and an increased incidence of morphological defects was also observed at 8 and 16 mg/kg/day. There were no differences between control and manganese-treated groups in the incidence of individual or total malformations. The no observable adverse effect level (NOAEL) for maternal toxicity of MnCl2· 4H20 in mice was 4 mg/kg/day, while the NOAEL for embryo/fetal toxicity was 2 mg/kg/day.

AB - Manganese (II) chloride tetrahydrate was investigated in Swiss mice for maternal and developmental toxicity after subcutaneous (s.c.) exposure to doses of 0, 2, 4, 8 and 16 mg/kg per day from gestation day 6 through 15. Females were sacrificed on gestation day 18, and fetuses were examined for external, visceral, and skeletal abnormalities. Maternal toxicity included significant reductions in weight gain and food consumption at 8 and 16 mg/kg/day, as well as several treatment-related deaths in the high dose-group. There were no treatment-related effects on the number of total implants, early resorptions, dead fetuses or sex ratio, whereas a significant increase in the number of late resorptions was found in the 4, 8, and 16 mg/kg/day groups. Fetotoxicity, consisting primarily of reduced fetal body weight and an increased incidence of morphological defects was also observed at 8 and 16 mg/kg/day. There were no differences between control and manganese-treated groups in the incidence of individual or total malformations. The no observable adverse effect level (NOAEL) for maternal toxicity of MnCl2· 4H20 in mice was 4 mg/kg/day, while the NOAEL for embryo/fetal toxicity was 2 mg/kg/day.

KW - Embryolethality

KW - Fetotoxicity

KW - Manganese (II) chloride

KW - Maternal Toxicity

KW - Mice

UR - http://www.scopus.com/inward/record.url?scp=0027198572&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027198572&partnerID=8YFLogxK

U2 - 10.1016/0378-4274(93)90144-M

DO - 10.1016/0378-4274(93)90144-M

M3 - Article

VL - 69

SP - 45

EP - 52

JO - Toxicology Letters

JF - Toxicology Letters

SN - 0378-4274

IS - 1

ER -